These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 29740742)

  • 1. Prospects for engineering dynamic CRISPR-Cas transcriptional circuits to improve bioproduction.
    Fontana J; Voje WE; Zalatan JG; Carothers JM
    J Ind Microbiol Biotechnol; 2018 Jul; 45(7):481-490. PubMed ID: 29740742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the applications of promoter engineering for the optimization of metabolite biosynthesis.
    Xu N; Wei L; Liu J
    World J Microbiol Biotechnol; 2019 Jan; 35(2):33. PubMed ID: 30706208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing Metabolic Engineering of Saccharomyces cerevisiae Using the CRISPR/Cas System.
    Lian J; HamediRad M; Zhao H
    Biotechnol J; 2018 Sep; 13(9):e1700601. PubMed ID: 29436783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR system in the yeast Saccharomyces cerevisiae and its application in the bioproduction of useful chemicals.
    Mitsui R; Yamada R; Ogino H
    World J Microbiol Biotechnol; 2019 Jul; 35(7):111. PubMed ID: 31280424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in metabolic engineering of Saccharomyces cerevisiae: New tools and their applications.
    Lian J; Mishra S; Zhao H
    Metab Eng; 2018 Nov; 50():85-108. PubMed ID: 29702275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria.
    Dong C; Fontana J; Patel A; Carothers JM; Zalatan JG
    Nat Commun; 2018 Jun; 9(1):2489. PubMed ID: 29950558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case study of xylose conversion to glycolate in Corynebacterium glutamicum: Current limitation and future perspective of the CRISPR-Cas systems.
    Lee SS; Park J; Heo YB; Woo HM
    Enzyme Microb Technol; 2020 Jan; 132():109395. PubMed ID: 31731968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic engineering tools in model cyanobacteria.
    Carroll AL; Case AE; Zhang A; Atsumi S
    Metab Eng; 2018 Nov; 50():47-56. PubMed ID: 29588234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toolboxes for cyanobacteria: Recent advances and future direction.
    Sun T; Li S; Song X; Diao J; Chen L; Zhang W
    Biotechnol Adv; 2018; 36(4):1293-1307. PubMed ID: 29729377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-coupled recombineering for metabolic engineering of Corynebacterium glutamicum.
    Cho JS; Choi KR; Prabowo CPS; Shin JH; Yang D; Jang J; Lee SY
    Metab Eng; 2017 Jul; 42():157-167. PubMed ID: 28649005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplex Genome Engineering for Optimizing Bioproduction in Saccharomyces cerevisiae.
    Auxillos JY; Garcia-Ruiz E; Jones S; Li T; Jiang S; Dai J; Cai Y
    Biochemistry; 2019 Mar; 58(11):1492-1500. PubMed ID: 30817136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced biotechnology: metabolically engineered cells for the bio-based production of chemicals and fuels, materials, and health-care products.
    Becker J; Wittmann C
    Angew Chem Int Ed Engl; 2015 Mar; 54(11):3328-50. PubMed ID: 25684732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current understanding of the cyanobacterial CRISPR-Cas systems and development of the synthetic CRISPR-Cas systems for cyanobacteria.
    Pattharaprachayakul N; Lee M; Incharoensakdi A; Woo HM
    Enzyme Microb Technol; 2020 Oct; 140():109619. PubMed ID: 32912679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Enabled Tools for Engineering Microbial Genomes and Phenotypes.
    Tarasava K; Oh EJ; Eckert CA; Gill RT
    Biotechnol J; 2018 Sep; 13(9):e1700586. PubMed ID: 29917318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Gene Regulation in Cyanobacteria.
    Immethun CM; Moon TS
    Adv Exp Med Biol; 2018; 1080():317-355. PubMed ID: 30091101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved bioethanol production using CRISPR/Cas9 to disrupt the ADH2 gene in Saccharomyces cerevisiae.
    Xue T; Liu K; Chen D; Yuan X; Fang J; Yan H; Huang L; Chen Y; He W
    World J Microbiol Biotechnol; 2018 Oct; 34(10):154. PubMed ID: 30276556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
    Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
    Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoters inducible by aromatic amino acids and γ-aminobutyrate (GABA) for metabolic engineering applications in Saccharomyces cerevisiae.
    Kim S; Lee K; Bae SJ; Hahn JS
    Appl Microbiol Biotechnol; 2015 Mar; 99(6):2705-14. PubMed ID: 25573467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of resveratrol and piceatannol in engineered microbial strains: achievements and perspectives.
    Shrestha A; Pandey RP; Sohng JK
    Appl Microbiol Biotechnol; 2019 Apr; 103(7):2959-2972. PubMed ID: 30798357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in metabolic engineering of Corynebacterium glutamicum for bioproduction of value-added aromatic chemicals and natural products.
    Kogure T; Inui M
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8685-8705. PubMed ID: 30109397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.